During the past decade, Erlanger Oncology & Hematology - Univ. of TN conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Erlanger Oncology & Hematology - Univ. of TN" #1 sponsor was "Bristol-Myers Squibb" with 5 trials, followed by "Calithera Biosciences, Inc" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "NovoCure GmbH" with 1 trials sponsored and "NovoCure Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erlanger Oncology & Hematology - Univ. of TN" #1 collaborator was "Ono Pharmaceutical Co. Ltd" with 4 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Erlanger Oncology & Hematology - Univ. of TN" are "Brain Cancer" (1 trials), "Brain Neoplasms" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Clear Cell Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Erlanger Oncology & Hematology - Univ. of TN" in a lesser frequency.

Most popular intervention types in "Erlanger Oncology & Hematology - Univ. of TN" are "Drug" (9 trials), "Biological" (2 trials), "Device" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (4 trials), "NovoTTF-200T" (2 trials), "Radiotherapy" (2 trials), "Temozolomide" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erlanger Oncology & Hematology - Univ. of TN" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Erlanger Oncology & Hematology - Univ. of TN". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Erlanger Oncology & Hematology - Univ. of TN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Erlanger Oncology & Hematology - Univ. of TN, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".